It’s been a busy week or so for news about COVID vaccines. First we heard preliminary clinical trial results from the Pfizer vaccine, then the Russian Sputnik V vaccine. This week, we heard about the Moderna vaccine. All these results were shared with the media, ahead of being peer reviewed and published in a journal.
The good news here is we are now seeing multiple vaccines with similar positive results. Moderna reports its COVID-19 vaccine is 94.5% effective in first data from Phase 3 trial https://t.co/taVsQfBYPW pic.twitter.com/z5CYp9p4RH
— Ward Plunet (@WardPlunet) November 16, 2020
As we expect